Loading...
XJPX
2796
Market cap34mUSD
Jul 10, Last price  
490.00JPY
1D
1.24%
1Q
-6.31%
Jan 2017
-7.20%
IPO
-3.50%
Name

Pharmarise Holdings Corp

Chart & Performance

D1W1MN
XJPX:2796 chart
P/E
49.88
P/S
0.08
EPS
9.82
Div Yield, %
2.89%
Shrs. gr., 5y
-0.74%
Rev. gr., 5y
5.85%
Revenues
69.51b
+9.45%
15,395,000,00018,576,000,00020,007,000,00023,416,897,00026,825,000,00029,607,057,00033,357,066,00038,221,039,00039,506,082,00048,511,570,00052,949,000,00054,562,000,00051,728,000,00051,030,000,00052,324,000,00051,608,000,00052,030,000,00054,466,000,00063,508,000,00069,512,000,000
Net income
113m
P
140,000,00096,000,000222,000,000276,576,000562,978,000685,818,000958,001,000369,094,000227,892,000382,195,0008,000,000-29,000,00023,000,000577,000,000425,000,000448,000,000333,000,000-351,000,000-368,000,000113,000,000
CFO
3.28b
+150.04%
-56,000,0001,480,409,0001,272,516,000807,366,000942,416,0002,283,834,0001,618,240,0001,306,121,0003,405,092,000-272,757,0002,103,000,0001,330,000,000895,000,0001,572,000,0001,945,000,000713,000,0002,520,000,0002,714,000,0001,311,000,0003,278,000,000
Dividend
May 28, 202614 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Pharmarise Holdings Corporation predominantly oversees a chain of pharmacies that dispense prescription medications throughout Japan. These establishments fulfill prescriptions provided by medical facilities, offering vital pharmaceutical services to patients. Beyond its primary dispensing activities, the company also manages drugstores and convenience stores, and retails cosmetic products. Additionally, it provides services including the safekeeping and administration of patient medical records for healthcare institutions, operates medical complex centers, and offers temporary staffing assistance. As of May 31, 2021, the corporation maintained a network of 347 outlets. Pharmarise Holdings Corporation was founded in 1984 and its main office is located in Tokyo, Japan.
IPO date
Feb 01, 2007
Employees
1,555
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑052025‑052024‑052023‑052022‑052021‑052020‑052019‑052018‑052017‑05
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT